Search Results
Feb 04, 2026, 08:20 ET Columbus McKinnon Completes Acquisition of Kito Crosby
& Ellis LLP and Simpson Thacher & Bartlett LLP are acting as legal advisors. Debevoise & Plimpton LLP is acting as legal advisor for CD&R, with Guggenheim Securities LLC acting as its financial advisor.About Columbus McKinnonColumbus McKinnon is a leading worldwide
More news about: Columbus McKinnon Corporation
Feb 04, 2026, 08:15 ET AGCO's Brands to Exhibit Full Range of Solutions at National Farm Machinery Show
equipment, now enhanced with intuitive, field–proven technology solutions like PTx FarmEngage™. The display will feature the MF 9S tractor alongside the 500R sprayer, planter and compact utility lineup, demonstrating the brand's commitment to delivering practical, high–performance equipment for every operation.
More news about: AGCO Corporation
Feb 04, 2026, 08:12 ET Midea Building Technologies、AHR Expo 2026で「スマート・イン・ワン」（Smart in One）統合ビルディングソリューションを展示
高負荷な冷却に対応する高効率遠心冷凍機MagBoost Apex Pro磁気軸受遠心冷凍機には、Mideaの特許取得済み第2世代オイルフリー磁気軸受システムが組み込まれており、HVAC技術の大きな進歩を表すソリューションです。この革新的な設計により、機械的な摩擦がなくなり、効率と運転の信頼性が向上しました。このユニットは、R1234ze(E)冷媒を使用した場合にIPLVが最大9.71という卓越した性能を発揮します。長寿命設計のコンプレッサーは、製品寿命が30年で保護等級はIP67となり、わずか70 dB（A）で作動します。モジュラー設計により、追加の制御なしに最大16台のユニッ
More news about: Midea Building Technologies
Feb 04, 2026, 08:02 ET Společnost Midea Building Technologies představuje na veletrhu AHR Expo 2026 integrovaná řešení pro budovy „Chytré v jednom"
při použití chladiva R1234ze(E). Kompresor je navržen pro dlouhou životnost, vydrží 30 let, má krytí IP67 a pracuje při hlučnosti pouhých 70 dB(A). Jeho modulární konstrukce umožňuje kombinovat až 16 jednotek bez dalších ovládacích prvků a podporuje chladiva R1234ze(E) i R513A, což snižuje dopad na životní
More news about: Midea Building Technologies
Feb 04, 2026, 08:00 ET Hesai and Grab Announce Strategic Partnership to Accelerate Lidar Deployment Across Southeast Asia
integrates its in-house manufacturing process with lidar R&D and design, enabling rapid product iteration while ensuring high performance, high quality and affordability. The Company's commercially validated solutions are backed by superior R&D capabilities across optics, mechanics, and electronics.
More news about: Hesai Technology
Feb 04, 2026, 08:00 ET MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel
peptide-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist. OXM is a naturally-occurring gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure, thus potentially resulting in superior body weight loss compared to selective GLP1R agonists. In
More news about: MetaVia Inc.
Feb 04, 2026, 08:00 ET APR RECORDS ANNUAL REVENUE OF KRW 1.53 TRILLION (USD 1.05 BILLION) WITH 24% OPERATING MARGIN IN 2025
expertise with advanced beauty technology.The company operates a diversified portfolio of beauty brands, including MEDICUBE (skincare), MEDICUBE AGE-R (home beauty devices), and Aprilskin (skincare), addressing a wide range of consumer needs across global markets. Through continuous innovation and consumer-centric
More news about: APR Corp.
Feb 04, 2026, 08:00 ET Des Hague and Jeff Sholl of RäFoods Assemble Industry-Leading Board of Directors to Accelerate the Living Nutrition™ Platform
OwnerDr. Susan Harlander brings more than 40 years of experience across food science, research, and product development. She has held senior R&D leadership roles at Land O'Lakes and the Green Giant Division of The Pillsbury Company and currently serves as Vice President of Technology at RäFoods.
More news about: RäFoods
Feb 04, 2026, 07:48 ET AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results
combination with rituximab and lenalidomide (R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the Phase 3 EPCORE FL-1 study in which Epkinly with R2 demonstrated significantly superior progression-free
More news about: AbbVie
Feb 04, 2026, 07:36 ET Midea Building Technologies presenta soluciones de construcción integradas "Smart in One" en AHR Expo 2026
utilizar refrigerante R1234ze(E). Diseñado para una larga vida útil, el compresor ofrece una vida útil de 30 años con protección IP67 y funciona a tan solo 70 dB(A). Su diseño modular permite combinar hasta 16 unidades sin controles adicionales, a la vez que admite refrigerantes R1234ze(E) y R513A para un menor
More news about: Midea Building Technologies
Feb 04, 2026, 07:33 ET Sungrow lance le PowerTitan 3.0, un système de stockage utilitaire grid-forming, à Madrid
ancrage localPrésent en Europe depuis 2011, Sungrow a développé un réseau régional comprenant 25 bureaux locaux, 2 centres R&D, 26 entrepôts et 3 centres de formation, technologie et service, avec son siège européen basé à Munich (Allemagne).Parmi
More news about: Sungrow
Feb 04, 2026, 07:30 ET DeFi Technologies Announces Venture Portfolio Company Stablecorp's Selection of VersaBank as Custodian for QCAD Digital Trust, Advancing Canada's First Compliant CAD Stablecoin
Feb. 4, 2026 /PRNewswire/ -- DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"), is pleased to announce
More news about: DeFi Technologies Inc.
Feb 04, 2026, 07:30 ET DeFi Technologies Announces Venture Portfolio Company Stablecorp's Selection of VersaBank as Custodian for QCAD Digital Trust, Advancing Canada's First Compliant CAD Stablecoin
- DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"),
More news about: DeFi Technologies Inc.
Feb 04, 2026, 07:25 ET Компания Midea Building Technologies представляет интегрированные решения для зданий «Smart in One» на выставке AHR Expo 2026
дБ(А). Его модульная конструкция позволяет объединить до 16 установок без дополнительных элементов управления, компрессор поддерживает хладагенты R1234ze(E) и R513A для снижения вредного воздействия на окружающую среду.Терморегулирующее решение для центров обработки данныхВ условиях
More news about: Midea Building Technologies
Feb 04, 2026, 07:20 ET Carolinas AGC Celebrates Awards-Winning Construction Projects Across the Carolinas
Triple-R ElectricAfter years of working from home during and post-COVID, Coastal Credit Union wanted to ensure its employees felt comfortable
More news about: Carolinas AGC
Feb 04, 2026, 07:13 ET The new plans commencing in 2026 within UPM share incentive arrangements
https://news.cision.com/upm-kymmene-oyj/r/the-new-plans-commencing-in-2026-within-upm-share-incentive-arrangements,c4302501
More news about: UPM-Kymmene Oyj
Feb 04, 2026, 07:07 ET More Than Powering Today: Sungrow launches Grid-Forming Utility ESS PowerTitan 3.0 in Madrid
plant.Global expertise and local footprintActive in Europe since 2011, Sungrow has expanded its regional presence to 25 local offices, two R&D centers, 26 warehouses and three Training & Technology and Service Centers, with its European headquarters located in Munich, Germany. Recent flagship
More news about: Sungrow
Feb 04, 2026, 06:55 ET Voltage Energy ogłasza nową lokalizację swojej międzynarodowej siedziby w Roxboro, w stanie Karolina Północna
CHAPEL HILL, Karolina Północna, 4 lutego 2026 r. /PRNewswire/ -- Założona w Karolinie Północnej spółka
More news about: Voltage Energy Group
Feb 04, 2026, 06:55 ET Johnson Controls Reports Strong Q1 Results; Raises FY26 Guidance
Residential and Light Commercial ("R&LC") HVAC business, including the North America Ducted business and the global Residential joint venture with Hitachi Global Life Solutions, Inc. ("Hitachi"), of which Johnson Controls owned 60% and Hitachi owned 40%. The R&LC HVAC business met the criteria
More news about: Johnson Controls International plc
Feb 04, 2026, 06:30 ET Cognizant Reports Fourth Quarter and Full-Year 2025 Results
provisions, repealed the requirement to capitalize U.S. research and experimental ("R&E") costs. As a result, we do not believe it is more likely than not that we will realize our deferred tax asset of $390 million related to R&E costs capitalized outside the United States. These amounts would have otherwise
More news about: Cognizant Technology Solutions Corporation
Feb 04, 2026, 05:52 ET SANY Marine and CEA Forge Strategic Telehandler and Material Handling Partnership in Australia
products, and prioritise future industry requirements," said Philip Cardaci, CFC Group Executive Chairman. "SANY's global manufacturing expertise with R&D centres and plants worldwide and their focus on electric and intelligent technology perfectly complement our existing and growing portfolio."With
More news about: SANY Group
Feb 04, 2026, 05:52 ET SANY Marine and CEA Forge Strategic Telehandler and Material Handling Partnership in Australia
products, and prioritise future industry requirements," said Philip Cardaci, CFC Group Executive Chairman. "SANY's global manufacturing expertise with R&D centres and plants worldwide and their focus on electric and intelligent technology perfectly complement our existing and growing portfolio."With
More news about: SANY Group
Feb 04, 2026, 05:24 ET ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT JANUARY 2026
https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-january-2026,c4302364The following files are available for download:
More news about: Zinzino
Feb 04, 2026, 05:02 ET Foresee Pharmaceuticals Receives the Fourth Positive Recommendation from the DSMB to Continue the Casppian Ph3 Study, for Central Precocious Puberty (CPP)
Pharmaceuticals Co., Ltd.Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (TPEx: 6576). Foresee's R&D efforts are focused on two key areas, namely its unique Stabilized Injectable Formulation (SIF) long-acting injectable (LAI) technology with derived
More news about: Foresee Pharmaceuticals Co., Ltd.
Feb 04, 2026, 04:38 ET Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease
pathology play a central role."Broadening the development focus for CS014 to PH-ILD is a natural and scientifically driven evolution," said Sten R. Sörensen, CEO of Cereno Scientific. "It enables us to target a severe condition with very limited treatment options and is expected to strengthen the
More news about: Cereno Scientific